Birte Christina Sauer (M. Sc.), Rainer Fietkau (Prof. Dr. Med.), Vratislav Strnad (Dr. med.), Christoph Bert (Prof. Dr.), Christopher Dürrbeck Dr.
{"title":"BP02 演讲时间:下午 4:09","authors":"Birte Christina Sauer (M. Sc.), Rainer Fietkau (Prof. Dr. Med.), Vratislav Strnad (Dr. med.), Christoph Bert (Prof. Dr.), Christopher Dürrbeck Dr.","doi":"10.1016/j.brachy.2024.08.026","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Interstitial brachytherapy of the breast is a well-established treatment option with very good clinical results. However, it is prone to human failures according to several safety reports [1-4], indicating that a timely detection and prevention of treatment errors is advised. An extensive patient specific quality assurance procedure could be implemented using electromagnetic tracking (EMT), which has shown its potential by enabling a line-of-sight independent and dose free tracing of implanted catheters or needles.</div></div><div><h3>Materials and Methods</h3><div>We retrospectively analyzed and categorized potential treatment errors in a cohort of 72 patients comprising more than 580 fractions and more than 8000 catheters. All patients were treated between October 2016 and November 2023 and participated in our EMT study. The implant geometry was assessed after each treatment fraction and after the planning CT by means of EMT. The detection and classification of errors is based on deviations between expected and measured catheter positions.</div></div><div><h3>Results</h3><div>Concerning planning errors, we did not find any (partial) swaps, but detected one inversion of the reconstruction direction (tip-end-swap). Before treatment delivery, we detected shifts larger than 0.8 mm in 35 % of all measured catheters, out of which 50 % were > 2 mm, 15 % were > 5 mm and 2 % were > 10 mm. The highest recorded shift reached 21.9 mm, the median magnitude was 3.0 mm. Delivery errors also included three swaps of neighboring catheters that were visually verified. It should be noted that the EMT enabled afterloader does not carry an active source, therefore, the transfer tubes had to be manually reconnected. This means that the detected swaps may not represent the clinical state, however, they provide an estimate for the probability of swaps to occur in clinical practice.</div></div><div><h3>Conclusions</h3><div>This study presents a first of its kind systematic treatment error analysis. It emphasizes the necessity for a patient specific quality assurance and treatment verification in interstitial breast brachytherapy to prevent potential errors, especially in view of ever shorter fractionation schemes.</div></div>","PeriodicalId":55334,"journal":{"name":"Brachytherapy","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"BP02 Presentation Time: 4:09 PM\",\"authors\":\"Birte Christina Sauer (M. Sc.), Rainer Fietkau (Prof. Dr. Med.), Vratislav Strnad (Dr. med.), Christoph Bert (Prof. Dr.), Christopher Dürrbeck Dr.\",\"doi\":\"10.1016/j.brachy.2024.08.026\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><div>Interstitial brachytherapy of the breast is a well-established treatment option with very good clinical results. However, it is prone to human failures according to several safety reports [1-4], indicating that a timely detection and prevention of treatment errors is advised. An extensive patient specific quality assurance procedure could be implemented using electromagnetic tracking (EMT), which has shown its potential by enabling a line-of-sight independent and dose free tracing of implanted catheters or needles.</div></div><div><h3>Materials and Methods</h3><div>We retrospectively analyzed and categorized potential treatment errors in a cohort of 72 patients comprising more than 580 fractions and more than 8000 catheters. All patients were treated between October 2016 and November 2023 and participated in our EMT study. The implant geometry was assessed after each treatment fraction and after the planning CT by means of EMT. The detection and classification of errors is based on deviations between expected and measured catheter positions.</div></div><div><h3>Results</h3><div>Concerning planning errors, we did not find any (partial) swaps, but detected one inversion of the reconstruction direction (tip-end-swap). Before treatment delivery, we detected shifts larger than 0.8 mm in 35 % of all measured catheters, out of which 50 % were > 2 mm, 15 % were > 5 mm and 2 % were > 10 mm. The highest recorded shift reached 21.9 mm, the median magnitude was 3.0 mm. Delivery errors also included three swaps of neighboring catheters that were visually verified. It should be noted that the EMT enabled afterloader does not carry an active source, therefore, the transfer tubes had to be manually reconnected. This means that the detected swaps may not represent the clinical state, however, they provide an estimate for the probability of swaps to occur in clinical practice.</div></div><div><h3>Conclusions</h3><div>This study presents a first of its kind systematic treatment error analysis. It emphasizes the necessity for a patient specific quality assurance and treatment verification in interstitial breast brachytherapy to prevent potential errors, especially in view of ever shorter fractionation schemes.</div></div>\",\"PeriodicalId\":55334,\"journal\":{\"name\":\"Brachytherapy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2024-10-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Brachytherapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1538472124001624\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brachytherapy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1538472124001624","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Interstitial brachytherapy of the breast is a well-established treatment option with very good clinical results. However, it is prone to human failures according to several safety reports [1-4], indicating that a timely detection and prevention of treatment errors is advised. An extensive patient specific quality assurance procedure could be implemented using electromagnetic tracking (EMT), which has shown its potential by enabling a line-of-sight independent and dose free tracing of implanted catheters or needles.
Materials and Methods
We retrospectively analyzed and categorized potential treatment errors in a cohort of 72 patients comprising more than 580 fractions and more than 8000 catheters. All patients were treated between October 2016 and November 2023 and participated in our EMT study. The implant geometry was assessed after each treatment fraction and after the planning CT by means of EMT. The detection and classification of errors is based on deviations between expected and measured catheter positions.
Results
Concerning planning errors, we did not find any (partial) swaps, but detected one inversion of the reconstruction direction (tip-end-swap). Before treatment delivery, we detected shifts larger than 0.8 mm in 35 % of all measured catheters, out of which 50 % were > 2 mm, 15 % were > 5 mm and 2 % were > 10 mm. The highest recorded shift reached 21.9 mm, the median magnitude was 3.0 mm. Delivery errors also included three swaps of neighboring catheters that were visually verified. It should be noted that the EMT enabled afterloader does not carry an active source, therefore, the transfer tubes had to be manually reconnected. This means that the detected swaps may not represent the clinical state, however, they provide an estimate for the probability of swaps to occur in clinical practice.
Conclusions
This study presents a first of its kind systematic treatment error analysis. It emphasizes the necessity for a patient specific quality assurance and treatment verification in interstitial breast brachytherapy to prevent potential errors, especially in view of ever shorter fractionation schemes.
期刊介绍:
Brachytherapy is an international and multidisciplinary journal that publishes original peer-reviewed articles and selected reviews on the techniques and clinical applications of interstitial and intracavitary radiation in the management of cancers. Laboratory and experimental research relevant to clinical practice is also included. Related disciplines include medical physics, medical oncology, and radiation oncology and radiology. Brachytherapy publishes technical advances, original articles, reviews, and point/counterpoint on controversial issues. Original articles that address any aspect of brachytherapy are invited. Letters to the Editor-in-Chief are encouraged.